!_ImageURLWeb_! https://ent.news/2025/1/1271.jpg

Riyadh-based IB Ventures launched a USD 50 mn investment platform focused on advancing biotechnology innovation and localizing key technologies in the Kingdom, according to a company statement. The initiative, billed as a first for the region, seeks to attract high-potential international biotech firms, support technology transfer, and nurture Saudi startups across therapeutics, diagnostics, digital biology, and bio-manufacturing.

(** Tap or click the headline above to read this story with all of the links to our background and outside sources.)

The program integrates venture funding with incubation and acceleration support, while fostering collaboration with global research partners in the US and Switzerland where IB Ventures is expanding internationally with new offices, Bridge Middle East reports. The move aligns with Saudi Arabia’s National Biotechnology Strategy.

What they said: "The initiative establishes an integrated investment path that links financing, expansion and exit, ensuring the sustainability of returns and attracting strategic investors to the vital sector,” General Partner at IB Ventures Mohammed Alangari (LinkedIn) said.

Tags: